Dual-engineered small extracellular vesicles targeted delivery miR-126 for reducing age-related bone loss
Biomedical Materials · 01.08.2026 · 21 (4) · 045010
DOI: 10.1088/1748-605x/ae7ee3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Materials, online erschienen am 13.07.2026. Verfasst von Junming Tao und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Oral an…. Hauptthemen laut MEDLINE: MicroRNAs, Extracellular Vesicles, Osteoporosis. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
MiRNA based nucleic acid therapeutics have been extensively investigated for the treatment of age-related diseases. However, efficient delivery of miRNA and effective therapy for age-related bone loss remain major challenges. In this study, we devised an engineered small extracellular vesicle (sEV) platform to address the dysregulation of bone homeostasis in the elderly. Initially, miR-126 was encapsulated into sEV to generate miR-126 loaded small extracellular vesicles (m-sEV), whose capacity to enhance vascularized bone regeneration was validated in vitro and in a mandibular defect model of aged rats. To further optimize systemic therapeutic efficacy, we functionalized m-sEV with a bone-targeting peptide:(DSS) 6 , thereby constructing bone-targeting engineered vesicles (Bm-sEV). Systemic administration of Bm-sEV enabled precise miR-126 targeted delivery to bone tissue, resulting in increased abundance of type H vessels in the femur, improved bone microarchitecture, and attenuation of age-related bone loss. Mechanistic analyses demonstrated that the angiogenesis-osteogenesis coupling effect was mediated by upregulation of endothelial Integrin β 3 (ITGB3), which subsequently activated the ITGB3/ERK2 signaling cascade. Notably, Bm-sEV also restored the profoundly impaired osteoclastic activity in aged femurs, thereby re-establishing skeletal homeostasis. Collectively, Our study provides a promising approach for the treatment of age-related bone loss by combining biological macromolecules such as (DSS) 6 and miR-126 with sEV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan U…
- Shenzhen Traditional Chinese Medicine Hospital, Shenzhen 518033, People's Republic of China.
- Applied Oral Sciences and Community Dental Care, Faculty of Dentistry, The University of Hong Kong, Hong Kong Special Administrative Region of China, People's Republic of China.
ORCID-Profile: Wei Jing
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Tao, J., Du, R., Zhang, Y., Hong, M., Duan, S., Fu, D., Chen, Y., Liang, C., & Jing, W. (2026). Dual-engineered small extracellular vesicles targeted delivery miR-126 for reducing age-related bone loss. Biomedical Materials, 21(4), 045010. https://doi.org/10.1088/1748-605x/ae7ee3
Vancouver
Tao J, Du R, Zhang Y, Hong M, Duan S, Fu D, et al. Dual-engineered small extracellular vesicles targeted delivery miR-126 for reducing age-related bone loss. Biomedical Materials. 2026;21(4):045010. doi:10.1088/1748-605x/ae7ee3
BibTeX
@article{Tao2026,
author = {Tao, Junming and Du, Ruiyu and Zhang, Yi and Hong, Mengru and Duan, Shaochen and Fu, Datian and Chen, Yue and Liang, Chao and Jing, Wei},
title = {Dual-engineered small extracellular vesicles targeted delivery miR-126 for reducing age-related bone loss},
journal = {Biomedical Materials},
year = {2026},
volume = {21},
number = {4},
pages = {045010},
doi = {10.1088/1748-605x/ae7ee3}
}
EUVIMED